BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9656)

  • 1. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
    Dunstan R; Jackson DM
    Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
    Dunstan R; Jackson DM
    Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of catecholamines on dexamphetamine-induced changes in locomotor activity.
    Handley SL; Thomas KV
    Psychopharmacology (Berl); 1978 Jul; 58(3):283-8. PubMed ID: 98799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence for a change in central alpha-adrenergic receptor sensitivity after withdrawal from long-term haloperidol treatment.
    Dunstan R; Jackson DM
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Jun; 303(2):153-6. PubMed ID: 209350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration.
    Bailey RC; Jackson DM
    Psychopharmacology (Berl); 1978 Apr; 56(3):317-26. PubMed ID: 418441
    [No Abstract]   [Full Text] [Related]  

  • 6. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents.
    Andén NE; Grabowska M; Strömbom U
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(1):43-52. PubMed ID: 6918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic L-DOPA treatment of mice: a behavioural and biochemical study.
    Bailey R; Crisp E; Jackson DM; Jenkins O
    J Neural Transm; 1981; 50(2-4):209-24. PubMed ID: 6787171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
    Dunstan R; Jackson DM
    J Neural Transm; 1977; 40(3):181-9. PubMed ID: 874470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
    Fayle P; Jackson DM; Jenkins OF; Lafferty PA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation.
    Liljequist S; Berggren U; Engel J
    J Neural Transm; 1981; 50(1):57-67. PubMed ID: 6110703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine supersensitivity on lateral hypothalamic self-stimulation in rats.
    Ettenberg A; Milner PM
    Pharmacol Biochem Behav; 1977 Dec; 7(6):507-14. PubMed ID: 563603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hyperkinetic syndrome following long-term haloperidol treatment: involvement of dopamine and noradrenaline.
    Jackson DM; Dunstan R; Perrington A
    J Neural Transm; 1979; 44(3):175-86. PubMed ID: 571456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Supersensitivity to dopaminergic agonists induced by haloperidol.
    Thornburg JE; Moore KE
    Natl Inst Drug Abuse Res Monogr Ser; 1975 Nov; (3):23-8. PubMed ID: 1241913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for stimulation of growth hormone secretion by a central noradrenergic system in dogs.
    Lovinger R; Holland J; Kaplan S; Grumbach M; Boryczka AT; Shackelford R; Salmon J; Reid IA; Ganong WF
    Neuroscience; 1976 Dec; 1(6):443-50. PubMed ID: 11370235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain.
    Jackson DM; Andén NE; Dahlström A
    Psychopharmacologia; 1975 Dec; 45(2):139-49. PubMed ID: 1215445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the mechanism of amphetamine-induced behavioural changes in the mouse. III. Effects of apomorphine and Fla 63.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(6):993-7. PubMed ID: 582011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Adrenergic modulation of hypothalamic self-stimulation: effects of phenoxybenzamine, yohimbine, dexamphetamine and their interactions with clonidine.
    Hunt GE; Atrens DM; Becker FT; Paxinos G
    Eur J Pharmacol; 1978 Dec; 53(1):1-8. PubMed ID: 216557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.